Global Health - Kazakhstan

• 
• 
• 
• 
• 
• 

Support for HIV/AIDS includes direct technical assistance to the MOH and other local partners to strengthen their HIV prevention, care, and treatment programs and their health systems capacity.

Specific activities include implementing evidence-based pilot programs to illustrate and test prevention programs, identifying and adopting cost effective modes of service delivery, and expanding prevention and related services for high-risk populations.

Similarly, focus areas for HIV care and treatment services include building the capacity of clinicians through training and on-the-job mentoring, strengthening HIV and opportunistic infection treatment and care services, developing clinical guidelines for screening and managing HIV infection, and enhancing screening for and diagnosis of HIV infection and coinfection.

To strengthen health systems CDC works with the MOHs to develop electronic surveillance and HIV case management systems, to improve program monitoring and evaluation systems, and to build workforce capacity in key areas. This includes the ability to assess and use data for informed decision-making and improved program performance.

The GDD Regional Center in Kazakhstan is part of the Central Asia Region Global Disease Detection Center, one of ten established around the world to help countries identify and respond to emerging diseases. The GDD Regional Center collaborates with key in-country partners in Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, and the Kyrgyz Republic, making it truly a regional platform in scope. GDD Regional Centers work with the World Health Organization and MOHs to strengthen core infrastructure requirements (e.g., laboratory detection, clinical surveillance, outbreak investigation and control) needed to comply with the International Health Regulations. GG operates the following four programs in Kazakhstan:

CDC IEIP staff work with key stakeholders to improve detection, control, and prevention of emerging infectious diseases. Strategies include strengthening epidemiology, surveillance, laboratory capability, training, and evidence-based public health research and practice. IEIP’s activities have led to improved understanding of the causes and burden of varying diseases such as hepatitis, influenza, and Crimean-Congo hemorrhagic fever (CCHF) in Kazakhstan, and the data have been used to inform public health policy decisions, to evaluate new tools for improving disease diagnosis and treatment, and to strengthen epidemiologic and laboratory capacity.

The CDC Division of Public Health Systems and Workforce Development has been working in Central Asia since 2003 to build workforce capacity and to support MOHs in training public health officers through a two-year regional Field Epidemiology Training Program (FETP). The FETP program focuses on applied epidemiology, disease surveillance, outbreak response, laboratory methods, and program evaluation. While enrolled, residents continue working in their respective country's health system and are well-positioned to serve as first responders to outbreaks, as well as to serve as leaders and mentors for future in-country specialists in field epidemiology.

Pandemic influenza response planning and preparedness activities are occurring throughout Kazakhstan. Seven sentinel surveillance sites for influenza-like illness and severe acute respiratory illness were established along with a national laboratory and a laboratory in each surveillance site.

The CBEP program is funded by the Department of Defense through its Defense Threat Reduction Agency (DTRA) with the goal of building epidemiologic, health information, clinical and laboratory capacity while focusing on biosecurity in the area of especially dangerous pathogens (EDPs), microbes which could be used for bioterrorism. The four-member CDC/CAR CBEP team, in collaboration with the MoH of Kazakhstan, is working on improving the public health capacity in Kazakhstan.

CDC is working with Kazakhstan to improve their ability to prevent, detect and respond to infectious disease threats.  This work helps meet the U.S. commitment to assist at least 31 countries in reaching the targets outlined in the Global Health Security Agenda. CDC’s extensive global health presence and experience are critical to achieving these targets.

Travel:

• U.S. Department of State International Travel Information: Kazakhstan
• Health Information for Travelers to Kazakhstan

General:

• US Embassy to Kazakhstan
• CIA Factbook: Kazakhstan
• Immigrant, Refugee and Migrant Health
• Registration of Traveler Emergency Contact and Itinerary Information
• Planning for Healthy Travel: Responsibilities & Resources
• Global Public Health Informatics Program (GPHIP): Country Programs & Partnerships

Diseases:

Infectious Diseases:

• Measles Update
• Human Infection with Avian Influenza A (H5N1) Virus: Advice for Travelers
• Guidelines and Recommendations: Interim Guidance about Avian Influenza (H5N1) for U.S. Citizens Living Abroad
• IMMPaCt - International Micronutrient Malnutrition Prevention and Control Program in Kazakhstan
• Progress Toward Tuberculosis Control and Determinants of Treatment Outcomes --- Kazakhstan, 2000--2002
• Historical Distribution and Molecular Diversity of Bacillus anthracis, Kazakhstan
• DPHSWD in Central Asia
• Report Summary for August 2011 Country Management and Support Visit to Central Asia Region
• Controlling Drug-Resistant TB Where It Is Most Prevalent
• Meningococcal Disease
• Outbreaks Following Wild Poliovirus Importations --- Europe, Africa, and Asia, January 2009--September 2010
• Seasonal Flu: WHO European Region (EUR)
• Information on Yellow Fever in Kazakhstan